Literature DB >> 9548498

Beta2 integrins are not required for tyrosine phosphorylation of paxillin in human neutrophils.

R Fernandez1, L A Boxer, S J Suchard.   

Abstract

Although many of the receptors mediating neutrophil (polymorphonuclear leukocyte (PMN)) adhesion to extracellular matrix (ECM) proteins have been identified, the signal transduction pathways leading to cell spreading are not clearly defined. Studies showing that protein tyrosine phosphorylation increases with PMN adhesion suggest that phosphorylation is critical for adhesion-dependent processes. In other cells, increased tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin are thought to play pivotal roles in ECM-mediated signaling. In the present study we compared the tyrosine phosphorylation of FAK and paxillin in PMNs plated onto thrombospondin (TSP) or laminin (LN). Increased tyrosine phosphorylation of paxillin correlated with adhesion and spreading of PMNs plated onto LN or TSP. In PMNs adherent to LN, the kinetics of FAK phosphorylation preceded the kinetics of paxillin phosphorylation, suggesting that paxillin may be a downstream target of FAK. In contrast, FAK was not phosphorylated in PMNs spread on TSP. These findings suggested activation of different signaling pathways in TSP- vs LN-adherent PMNs. Others have proposed that paxillin phosphorylation requires beta2 integrins. Therefore, we used PMNs from a patient with leukocyte adhesion deficiency (LAD), lacking beta2 integrins, to determine whether these receptors were necessary for paxillin phosphorylation. LAD PMNs did not adhere to LN, and consequently, there was no tyrosine phosphorylation of FAK or paxillin. In contrast, paxillin, but not FAK, was phosphorylated in LAD PMNs adherent and spread on TSP. These results indicate that ECM-beta2 integrin-mediated signaling initiates the FAK/paxillin signaling pathway(s), while TSP-mediated signaling results in paxillin phosphorylation independent of FAK phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9548498

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF.

Authors:  M Fuortes; M Melchior; H Han; G J Lyon; C Nathan
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Use of green fluorescent protein-conjugated beta-actin as a novel molecular marker for in vitro tumor cell chemotaxis assay.

Authors:  L Hodgson; W Qiu; C Dong; A J Henderson
Journal:  Biotechnol Prog       Date:  2000 Nov-Dec

3.  [Ca2+]i as a potential downregulator of alpha2beta1-integrin-mediated A2058 tumor cell migration to type IV collagen.

Authors:  L Hodgson; C Dong
Journal:  Am J Physiol Cell Physiol       Date:  2001-07       Impact factor: 4.249

4.  Live cell imaging of paxillin in rolling neutrophils by dual-color quantitative dynamic footprinting.

Authors:  Prithu Sundd; Edgar Gutierrez; Brian G Petrich; Mark H Ginsberg; Alex Groisman; Klaus Ley
Journal:  Microcirculation       Date:  2011-07       Impact factor: 2.628

5.  Focal adhesion kinase (FAK) deficiency in mononuclear phagocytes alters murine breast tumor progression.

Authors:  Ryan A Llewellyn; Michael F Gutknecht; Keena S Thomas; Mark R Conaway; Amy H Bouton
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

6.  Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8)-mediated human neutrophil chemotaxis.

Authors:  Vito Di Cioccio; Raffaele Strippoli; Cinzia Bizzarri; Giulia Troiani; Maria Neve Cervellera; Isabelle Gloaguen; Antonella Colagrande; Elisa Margherita Cattozzo; Sabrina Pagliei; Angela Santoni; Francesco Colotta; Fabrizio Mainiero; Riccardo Bertini
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

7.  Proline-rich tyrosine kinase 2 regulates spreading and migration of eosinophils after beta2-integrin adhesion.

Authors:  Xiangdong Zhu; Evan Boetticher; Lin Wang; Yingli Duan; Jonathan Learoyd; Alan R Leff
Journal:  Am J Respir Cell Mol Biol       Date:  2008-03-26       Impact factor: 6.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.